Abstract
Self-treatment of cancer with cesium chloride, despite proven lack of efficacy, continues to produce serious adverse effects. Among these is hypokalemia predisposing to life-threatening arrhythmia. The mechanism of cesium-associated hypokalemia (CAH) has not been described. We report urinary potassium wasting responsive to amiloride therapy in a cancer patient with CAH, and discuss possible mechanisms.
Original language | English (US) |
---|---|
Pages (from-to) | 335-338 |
Number of pages | 4 |
Journal | Clinical Kidney Journal |
Volume | 8 |
Issue number | 3 |
DOIs | |
State | Published - Jun 2015 |
Externally published | Yes |
Keywords
- Cancer
- Cesium
- Hypokalemia
ASJC Scopus subject areas
- Nephrology
- Transplantation